X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development

BioPharma Dynamics unveil brand new cleanroom facility to support the Life Sciences Industry

Content Team by Content Team
26th October 2021
in Drug Development, Press Statements
BioPharma Dynamics unveil brand new cleanroom facility to support the Life Sciences Industry

BioPharma Dynamics, a leading life sciences solution provider, proudly announce the opening of their new ISO Class 7 cleanroom facility located at new headquarters in Salford, Greater Manchester. This expansion sees the company treble in size, with its new premises adding the capacity for product assembly and increased warehouse and office space.

The exciting new single-use assembly cleanroom facility has been custom designed and manufactured to accommodate the increasing needs of the UK’s life sciences industry. Matched with their strong partnerships with a portfolio of market-leading manufacturers, the expansion will enable BioPharma Dynamics to provide a complete design-to-supply service, through high-quality production of assemblies at improved lead times.

BioPharma Dynamics are proud to create new jobs for the local area, with the addition of cleanroom technicians and warehousing staff to their thriving team. This new expansion sits just a stone’s throw from the bustling technological metropolis of Media City UK and is supremely located within the cluster of Life Sciences ventures in the North West.

Marking a new era for the company, who have continually built a strong reputation as customer-first supplier to the Life Sciences & Pharmaceutical industry. This expansion features dedicated warehouse and office space, to facilitate BioPharma Dynamics’ commitment to providing first-rate customer service and support.

Formed in 2008, BioPharma Dynamics began as a division of parent company, Action-Sealtite. Building from the ground up, they grew to become a standalone company trading as BioPharma Dynamics Ltd in September 2015, doubling in size and further expanded to opening a dedicated sales and marketing office. This newest expansion for BioPharma Dynamics follows a period of exponential growth piloted by Joe Brennan, Managing Director.

About BioPharma Dynamics
BioPharma Dynamics are a market-leading single-use solutions provider for the Life Sciences & Pharmaceutical industry, with ISO 9001 & 14001 accreditations. Committed to providing the most cost-effective solution for customers, using the latest single-use products, from the most innovative manufacturers in the marketplace. Based in the UK, BioPharma Dynamics are dedicated to serving the UKs outstanding Cell and Gene Therapy industry, keeping them up to date with the latest developments in single-use solutions specific for their needs.

Previous Post

Aptar Pharma Enters into Partnership with Stallergenes Greer to Develop Novel Digital Health Ecosystem for Allergen Immunotherapy Treatment

Next Post

Thrombolytic Science Granted US Patent on Novel Clot Dissolving Therapy, Complementing Patent Protection in Europe, Japan, China, Hong Kong, Mexico & CIS

Related Posts

Avadel Pharmaceuticals Receives
Drug Development

Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

9th June 2025
Robots and AI in Drug
Articles

Robots and AI in Drug Discovery Are Transforming Medicine

29th May 2025
Stringent Policy around COVID Vaccines Laid by FDA
FDA Approvals

Stringent Policy around COVID Vaccines Laid by FDA

29th May 2025
Pharmaceutical-Chemicals Market Booms with Rising API Demand
Asia

Pharmaceutical Chemicals Market Booms with Rising API Demand

28th May 2025
Next in Pharma 2025 Innovations
Articles

Next in Pharma 2025: Innovations Shaping the Future

28th May 2025
Insights

Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

27th May 2025
Next Post
FDA Approves Eli Lilly Precision Oncology Treatment for Certain Lung and Thyroid Cancers

Thrombolytic Science Granted US Patent on Novel Clot Dissolving Therapy, Complementing Patent Protection in Europe, Japan, China, Hong Kong, Mexico & CIS

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In